Top of this page
Skip navigation, go straight to the content
| € million | Actual 2010 | Actual 2009 | Actual 2008 | Actual 2007 |
|---|---|---|---|---|
| Revenue | 3 218 | 3 116 | 3 601 | 3 626 |
| Net sales | 2 786 | 2 683 | 3 027 | 3 188 |
| Royalty income & fees | 220 | 227 | 396 | 294 |
| Other revenue | 212 | 206 | 178 | 144 |
| Gross profit | 2 165 | 2 091 | 2 455 | 2 579 |
| Marketing and selling expenses | -797 | -781 | -928 | -1 054 |
| Research and development expenses | -705 | -674 | -767 | -788 |
| General and administrative expenses | -194 | -189 | -227 | -267 |
| Other operating income / expenses (-) | -2 | 6 | -1 | 10 |
| Recurring EBIT (REBIT) | 467 | 453 | 531 | 480 |
| Non recurring income / expenses (-) | -263 | 384 | -417 | -136 |
| EBIT (operating profit) | 204 | 837 | 113 | 344 |
| Net financial expenses | -185 | -162 | -156 | -125 |
| Profit / loss (-) before income taxes | 19 | 675 | -43 | 219 |
| Income tax expenses (-) / credit | 86 | -168 | 30 | -60 |
| Net profit (after minority interest) | 103 | 513 | 42 | 160 |
| Recurring EBITDA | 731 | 698 | 733 | 741 |
| € million | 2010 Dec. 31 | 2009 Dec. 31 | 2008 Dec. 31 | 2007 Dec. 31 Restated |
|---|---|---|---|---|
| Non-current assets | 7 238 | 7 326 | 7 687 | 7 900 |
| Current assets | 1 731 | 1 794 | 1 837 | 1 782 |
| Total assets | 8 969 | 9 120 | 9 524 | 9 682 |
| Shareholders' equity | 4 592 | 4 417 | 4 017 | 4 264 |
| Non-current liabilities | 2 524 | 2 641 | 2 953 | 3 404 |
| Current liabilities | 1 853 | 2 062 | 2 554 | 2 014 |
| Total liabilities and shareholders' equity | 8 969 | 9 120 | 9 524 | 9 682 |
| € million | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|
| Net profits (after minority interests) | 103 | 513 | 42 | 160 |
| Cash flow from operating activities | 506 | 295 | 366 | 490 |
| Cash flow from investing activities | -63 | 473 | -673 | -201 |
| Cash flow from financing activities | -440 | -736 | 278 | -766 |
| Change in cash and cash equivalents | 3 | 32 | -10 | -478 |